文献速递新发突发、热带与寄生虫病

VAR2CSA特异性免疫球蛋白G的Fc去岩藻糖基化与妊娠期恶性疟原虫疟疾临床免疫

Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria.
PubMed 文献 · J Infect Dis · 2025-01-01

研究通过改良酶联免疫吸附试验测定孕妇血浆中VAR2CSA特异性IgG水平及Fc去岩藻糖基化,并评估其抑制感染红细胞黏附和诱导自然杀伤细胞脱颗粒的能力。结果显示Fc去岩藻糖基化的VAR2CSA特异性IgG可有效诱导NK细胞脱颗粒,并与低出生体重保护相关,且独立于IgG水平。

要点

  • 产次与VAR2CSA特异性IgG水平、Fc去岩藻糖基化、出生体重及体外抑制IE黏附正相关。
  • Fc去岩藻糖基化VAR2CSA特异性IgG可增加NK细胞脱颗粒。
  • 具有Fc去岩藻糖基化VAR2CSA特异性IgG的妇女低出生体重风险降低,但疟疾或贫血风险未降低。

核心结论

  • Fc去岩藻糖基化的VAR2CSA特异性IgG有效诱导NK细胞脱颗粒,并与低出生体重保护相关,独立于IgG水平。

研究设计与样本

  • 测量孕妇血浆VAR2CSA特异性IgG水平及Fc去岩藻糖基化,并检测IgG抑制IE黏附和诱导NK细胞脱颗粒能力,结果与产次及妊娠结局关联。

主要发现

  • 产次与VAR2CSA特异性IgG水平、Fc去岩藻糖基化、出生体重及血浆IgG体外抑制IE黏附正相关。
  • Fc去岩藻糖基化VAR2CSA特异性IgG增加NK细胞脱颗粒。
  • 具有Fc去岩藻糖基化VAR2CSA特异性IgG的妇女低出生体重风险降低,但胎盘疟疾或贫血风险未降低。

临床怎么用

  • 作者认为研究对开发仅诱导Fc岩藻糖基化IgG的VAR2CSA亚单位疫苗有启示。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acquired immunity to Plasmodium falciparum malaria is mainly mediated by immunoglobulin G (IgG) targeting erythrocyte membrane protein 1 (PfEMP1). These adhesins mediate infected erythrocyte (IE) sequestration, protecting IEs from splenic destruction. PfEMP1-specific IgG is therefore thought to protect mainly by inhibiting IE sequestration. VAR2CSA-type PfEMP1 mediates placental IE sequestration, putting pregnant women exposed to P falciparum parasites at risk of placental malaria (PM). METHODS: Levels and Fc-afucosylation of VAR2CSA-specific plasma IgG were measured by a modified enzyme-linked immunosorbent assay (FEASI). We also measured the ability of the IgG to inhibit IE adhesion and to induce natural killer (NK) cell degranulation. The results were related to parity and clinical pregnancy outcomes. RESULTS: Parity was positively correlated with levels and Fc-afucosylation of VAR2CSA-specific IgG, and with birth weight and plasma IgG inhibition of IE adhesion in vitro. Fc-afucosylation of VAR2CSA-specific IgG increased NK-cell degranulation. Women with Fc-afucosylated VAR2CSA-specific IgG had a reduced risk of delivering a low birth weight (LBW) baby, but not of PM or anemia. CONCLUSIONS: Fc-afucosylated VAR2CSA-specific IgG effectively induced NK-cell degranulation and was associated with protection against LBW, independent of IgG levels. Our study has implications for the development of VAR2CSA-based subunit vaccines, which exclusively induce Fc-fucosylated IgG.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lopez-Perez M, Viwami F, Ampomah P, et al. Fc-Afucosylation of VAR2CSA-Specific Immunoglobulin G and Clinical Immunity to Placental Plasmodium falciparum Malaria. J Infect Dis. 2025. PMID: 39585195. doi:10.1093/infdis/jiae529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。